0 results available. Select is focused ,type to refine list, press Down to open the menu,
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The ...
The following section summarizes insights on Vaccinex Inc's Net Payout Yield:
We've identified the following companies as similar to Vaccinex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Payout Yield in the valuation category include:
Net Payout Yield is defined as:
Dividend Yield
(+) Buyback Yield
(=) Net Payout Yield
Net-payout yield measures the cash dividend plus net stock repurchases over the trailing twelve months divided by the company’s market capitalization.
Read more about shareholder yield, dividend yield, buyback yield, and debt paydown yield
The chart above depicts the distribution of net payout yield for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,367 had meaningful values. The average net payout yield of companies in the sector is -21.2% with a standard deviation of 55.8%.
Vaccinex Inc's Net Payout Yield of -654.9% is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,465 |
| Included Constituents | 2,367 |
| Min | -489.7% |
| Max | 9.3% |
| Median | -0.3% |
| Mean | -21.2% |
| Standard Deviation | 55.8% |
You can find companies with similar net payout yield using this stock screener.